Access to High-Cost Targeted Treatments Varies for Lung Cancer

THURSDAY, Dec. 12, 2019 -- Not all patients have access to new, high-cost lung cancer drugs, according to a study recently published in the Journal of the National Cancer Institute. Cathy J. Bradley, Ph.D., from University of Colorado in Aurora, and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news